Next Quarterly Earnings
Thursday, August 6, 2026
CW 32
After-Hours
In 32 days
Lineage Cell Therapeutics is a US-based biopharmaceutical company dedicated to the development and commercialization of allogeneic cell therapies. The company leverages pluripotent stem cells to research and clinically develop innovative regenerative medicine solutions for serious diseases, focusing on creating novel treatment options.